Meeting
Abstract Number: 165
SHM Converge 2023
Background: Approximately one-third of patients with acute ischemic stroke (AIS) develop hyperglycemia regardless of pre-existing history of diabetes [1]. Hyperglycemia is associated with increased risk of hemorrhagic transformation and can be considered as a predictor of poor functional outcome after intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) [2]. Additionally, risk of death, hemorrhagic complications, and […]
Abstract Number: 369
SHM Converge 2023
Background: Admitted patients with Type II Diabetes Mellitus (T2DM) are often placed on sliding scale insulin with four fingerstick blood glucose (FSBG) tests per day, regardless of home insulin use or baseline glycemic control. FSBG testing in the inpatient setting allows for real-time insulin adjustment to protect patients from significant hypo- or hyperglycemia, but FSBG […]